Literature DB >> 31286227

Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods.

Vinisha Ranna1, Karis Kin Fong Cheng2, Daniel A Castillo3, Lorraine Porcello4, Anusha Vaddi5, Rajesh V Lalla6, Paolo Bossi7, Sharon Elad5.   

Abstract

New studies and literature continue to emerge on the management of mucositis secondary to cancer therapy. The evidence-based clinical practice guidelines for mucositis were first published in 2004 and updated in 2007 and 2014 by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). The existing 2014 guidelines for mucositis are being updated in line with new literature to inform clinical practice. This paper describes the materials and methods employed for the comprehensive updates to the guidelines for managing mucositis.

Entities:  

Keywords:  Cancer; Cancer therapy; Data management; Guidelines; Methods; Mucositis; Systematic review

Mesh:

Year:  2019        PMID: 31286227     DOI: 10.1007/s00520-019-04891-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  10 in total

1.  Rating the quality of evidence for clinical practice guidelines.

Authors:  D C Hadorn; D Baker; J S Hodges; N Hicks
Journal:  J Clin Epidemiol       Date:  1996-07       Impact factor: 6.437

2.  Heart failure: evaluation and care of patients with left ventricular systolic dysfunction.

Authors:  M A Konstam; K Dracup; D W Baker; M B Bottorff; N H Brooks; R A Dacey; S B Dunbar; A B Jackson; M Jessup; J C Johnson
Journal:  J Card Fail       Date:  1995-03       Impact factor: 5.712

3.  Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process.

Authors:  Sharon Elad; Joanne Bowen; Yehuda Zadik; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2012-10-13       Impact factor: 3.603

4.  Development of the AHCPR-sponsored heart failure guideline: methodologic and procedural issues.

Authors:  D C Hadorn; D Baker
Journal:  Jt Comm J Qual Improv       Date:  1994-10

5.  Radiochemotherapy with amifostine cytoprotection for head and neck cancer.

Authors:  J Büntzel; J Schuth; K Küttner; M Glatzel
Journal:  Support Care Cancer       Date:  1998-03       Impact factor: 3.603

6.  Updated clinical practice guidelines for the prevention and treatment of mucositis.

Authors:  Dorothy M Keefe; Mark M Schubert; Linda S Elting; Stephen T Sonis; Joel B Epstein; Judith E Raber-Durlacher; Cesar A Migliorati; Deborah B McGuire; Ronald D Hutchins; Douglas E Peterson
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

Review 7.  Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.

Authors:  Stephen T Sonis; Linda S Elting; Dorothy Keefe; Douglas E Peterson; Mark Schubert; Martin Hauer-Jensen; B Nebiyou Bekele; Judith Raber-Durlacher; J Peter Donnelly; Edward B Rubenstein
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

8.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

9.  Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update.

Authors:  J M Bowen; S Elad; R D Hutchins; R V Lalla
Journal:  Support Care Cancer       Date:  2012-09-09       Impact factor: 3.603

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860

  10 in total
  12 in total

1.  The MASCC/ISOO mucositis guidelines 2019: the second set of articles and future directions.

Authors:  Sharon Elad
Journal:  Support Care Cancer       Date:  2020-05       Impact factor: 3.603

2.  Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents.

Authors:  Noam Yarom; Allan Hovan; Paolo Bossi; Anura Ariyawardana; Siri Beier Jensen; Margherita Gobbo; Hanan Saca-Hazboun; Abhishek Kandwal; Alessandra Majorana; Giulia Ottaviani; Monica Pentenero; Narmin Mohammed Nasr; Tanya Rouleau; Anna Skripnik Lucas; Nathaniel Simon Treister; Eyal Zur; Vinisha Ranna; Anusha Vaddi; Andrei Barasch; Rajesh V Lalla; Karis Kin Fong Cheng; Sharon Elad
Journal:  Support Care Cancer       Date:  2020-02-13       Impact factor: 3.603

3.  Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  Deborah P Saunders; Tanya Rouleau; Karis Cheng; Noam Yarom; Abhishek Kandwal; Jamie Joy; Kivanc Bektas Kayhan; Marianne van de Wetering; Norman Brito-Dellan; Tomoko Kataoka; Karen Chiang; Vinisha Ranna; Anusha Vaddi; Joel Epstein; Rajesh V Lalla; Paolo Bossi; Sharon Elad
Journal:  Support Care Cancer       Date:  2020-02-12       Impact factor: 3.603

4.  MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients.

Authors:  Wanessa Miranda-Silva; Wagner Gomes-Silva; Yehuda Zadik; Noam Yarom; Abdul Rahman Al-Azri; Catherine H L Hong; Anura Ariyawardana; Deborah P Saunders; M Elvira Correa; Praveen R Arany; Joanne Bowen; Karis Kin Fong Cheng; Wim J E Tissing; Paolo Bossi; Sharon Elad
Journal:  Support Care Cancer       Date:  2020-11-06       Impact factor: 3.603

5.  Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  M Elvira P Correa; Karis Kin Fong Cheng; Karen Chiang; Abhishek Kandwal; Charles L Loprinzi; Takehiko Mori; Carin Potting; Tanya Rouleau; Juan J Toro; Vinisha Ranna; Anusha Vaddi; Douglas E Peterson; Paolo Bossi; Rajesh V Lalla; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-12-14       Impact factor: 3.603

6.  Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  Richard M Logan; Abdul Rahman Al-Azri; Paolo Bossi; Andrea M Stringer; Jamie K Joy; Yoshihiko Soga; Vinisha Ranna; Anusha Vaddi; Judith E Raber-Durlacher; Rajesh V Lalla; Karis Kin Fong Cheng; Sharon Elad
Journal:  Support Care Cancer       Date:  2020-02-21       Impact factor: 3.603

7.  The MASCC/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles.

Authors:  Sharon Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.359

8.  A pilot study of the effect of a home-based multimodal symptom-management program in children and adolescents undergoing chemotherapy.

Authors:  Karis Kin-Fong Cheng; Laura Mei Lian Tan
Journal:  Cancer Rep (Hoboken)       Date:  2021-02-15

9.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Sharon Elad; Karis Kin Fong Cheng; Rajesh V Lalla; Noam Yarom; Catherine Hong; Richard M Logan; Joanne Bowen; Rachel Gibson; Deborah P Saunders; Yehuda Zadik; Anura Ariyawardana; Maria Elvira Correa; Vinisha Ranna; Paolo Bossi
Journal:  Cancer       Date:  2020-07-28       Impact factor: 6.860

Review 10.  Strategies to Mitigate Chemotherapy and Radiation Toxicities That Affect Eating.

Authors:  Peter M Anderson; Stefanie M Thomas; Shauna Sartoski; Jacob G Scott; Kaitlin Sobilo; Sara Bewley; Laura K Salvador; Maritza Salazar-Abshire
Journal:  Nutrients       Date:  2021-12-08       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.